Abstract
FACTORS controlling central nervous system (CNS) growth immediately after neurulation are mostly unknown. Vasoactive intestinal peptide (VIP) receptors are widely distributed in the embryonic nervous system1,2, and VIP has trophic and mitogenic properties3,4 on embryonic neural tissues but inhibits growth5 and mitosis in certain tumours6. To address the potential effects of VIP on embryonic growth, we used whole postimplantation embryo cultures7,8. After a 4-h incubation, VIP stimulated growth, increasing somite number, embryonic volume, DNA and protein content, and number of cells in S-phase. A VIP antagonist9,10 substantially inhibited these VIP-mediated increments in growth. The VIP antagonist completely suppressed VIP-stimulated mitosis in the CNS while decreasing the same in non-neuronal tissues by 38%. In vitro autoradiography revealed GTP-sensitive and GTP-insensitive VIP receptors which were differentially regulated in VIP antagonist-treated embryos. The present study suggests that VIP acts as a growth factor on early postimplantation embryos through multiple VIP receptors that exhibit tissue-specific responses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hill, J. M., Tanner, A. C., Agoston, D. V. & McCune, S. K. Soc. Neurosci. Abst. 17, 1126 (1991).
Hill, J. M. & McCune, S. K. Soc. Neurosci. Abst. 18, 1294 (1992).
Brenneman, D. E., Eiden, L. E. & Siegel, R. E. Peptides 6, 35–39 (1985)
Brenneman, D. E. & Eiden, L. E. Proc. natn Acad Sci. U.S.A. 83, 1159–1162 (1986).
Poston, G. J. et al. Pancreas 3, 439–443 (1988).
Alle, J. M. et al. J. Neuro-oncol. 3, 197–202 (1985).
New, D. A. T. in Methods in Mammalian Embryology (ed. Daniel, J. C. Jr) 305–319 (Freeman, San Francisco, 1971).
Van Maele-Fabry, G., Debras, J. P., Francois, I., Boucau, M. & Picard, J. J. Archs Biol. 99, 431–453 (1988).
Gozes, I. Meltzer, E., Rubinrout, S. & Brenneman, D. E. Endocrinology 125, 2945–2949 (1989).
Gozes, I. et al. J. Pharmac. exp. Ther. 257, 959–966 (1991).
Brown, N. A. & Fabro, S. Teratology 24, 65–78 (1981).
Theiler, K. (ed. )The House Mouse (Springer, Berlin, 1975).
Gressens, P. et al. J. Neuropath. exp. Neurol. 51, 206–219 (1992).
Gratzner, H. G. Science 218, 474–475 (1982).
Hill, J. M., Harris, A., & Hilton-Clarke, D. I. Neuroscience 48, 925–932 (1992).
Haegerstrand, A., Jonzon, B., Dalsgaard, C. J. & Nilsson, J. Proc. natn. Acad. Sci. U.S.A. 86, 5993–5996 (1989).
Pincus, D. W., DiCicco-Bloom, E. M. & Black, I. Nature 343, 564–567 (1990).
Scholar, E. M. & Paul, S. Cancer 67, 1561–1564 (1991).
Brenneman, D. E., Neale, E. A., Foster, G. A., d'Autremont, S. & Westbrook, G. L. J. Cell Biol. 104, 1603–1610 (1987).
Brenneman, D. E., Nicol, T., Warren, D. & Bowers, L. M. J. Neurosci. Res. 25, 386–394 (1990).
Tsutsui, Y. & Naruse, I. Am. J. Path. 127, 262–270 (1987).
Gozes, I., Schachter, P., Shani, Y. & Giladi, E. Neuroendocrinology 47, 27–31 (1988).
Emson, P. C. et al. Brain Res. 177, 437–444 (1979).
McGregor, G. P. et al. Neurosci. Lett. 28, 21–27 (1982).
Masuo, Y., Ohtaki, T., Masuda, Y., Tsuda, M. & Fujino, M. Brain Res. 575, 113–123 (1992).
Heyner, S., Farber, M. & Rosenblum, I. Y. in Current Topics in Developmental Biology Vol. 24 (ed. Nilsen-Hamilton, M.) 137–160 (Academic, San Diego, 1990).
Gozes, Y., Brenneman, D. E., Fridkin, M., Asofsky, R. & Gozes, I. Brain Res. 540, 319–321 (1991).
Burton, K. Biochem. J. 62, 315–323 (1956).
Munro, H. N. Meth. biochem. Analysis 14, 113–176 (1968).
Bradford, M. Analyt. Biochem. 72, 248–254 (1976).
Pincus, D. W., DiCicco-Bloom, E. M. & Black, I. B. Nature 343, 564–567 (1990).
Takahashi, T., Nowakowski, R. S. & Caviness, V. S. Jr J. Neurocytol. 21, 185–197 (1992).
Audigier, S., Barberis, C. & Jard, S. Brain Res. 376, 363–367 (1986).
Russell, J. T., Fatalis, A., Nelson, P. G. & Brenneman, D. E. Soc. Neurosci. Abstr. 16, 194 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gressens, P., Hill, J., Gozes, I. et al. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362, 155–158 (1993). https://doi.org/10.1038/362155a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/362155a0
This article is cited by
-
Bisphenol A affects vipergic nervous structures in the porcine urinary bladder trigone
Scientific Reports (2021)
-
Sex-and Region-Dependent Expression of the Autism-Linked ADNP Correlates with Social- and Speech-Related Genes in the Canary Brain
Journal of Molecular Neuroscience (2020)
-
Vasoactive Intestinal Peptide induces glucose and neutral amino acid uptake through mTOR signalling in human cytotrophoblast cells
Scientific Reports (2019)
-
Vasoactive Intestinal Peptide modulates trophoblast-derived cell line function and interaction with phagocytic cells through autocrine pathways
Scientific Reports (2016)
-
Epithelial Expression of Vasoactive Intestinal Peptide in Ulcerative Colitis: Down-Regulation in Markedly Inflamed Colon
Digestive Diseases and Sciences (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.